James P. Bowers

James P. Bowers serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions within a mission-critical scientific and medical support environment. He ensures compliance with FAR and agency-specific procurement policies while executing competitive solicitations for high-value goods and services. His portfolio centers on complex procurements requiring technical expertise in biotechnology, life sciences research, and medical supply chain logistics. Bowers works closely with program managers and technical evaluators to define requirements, draft solicitation documents, and conduct source selection processes that align with national health and research priorities. While no specific contractor relationships are identified in current data, Bowers routinely engages with a diverse pool of vendors including medical wholesalers, biotechnology manufacturers, and life sciences R&D firms. His procurement approach emphasizes fair and open competition, with a preference for vendors possessing demonstrated capability in regulated environments and GMP-compliant production. He maintains structured vendor engagement practices, including pre-solicitation outreach and post-award performance evaluations, to ensure accountability and mission alignment. Bowers consistently prioritizes full and open competition, with 100% of his acquisitions conducted without set-asides. This reflects a strategic alignment with mission requirements that demand specialized technical capabilities often found only among large, established industry players. While small business participation is not formally targeted through socioeconomic programs, his processes remain compliant with all applicable small business statutes and encourage voluntary participation where capabilities align. His primary procurement focus lies in NAICS 423450 for medical and hospital equipment distribution, and 541714, 541715, and 325414 for biotechnology research, life sciences R&D, and biological product manufacturing. He specializes in procuring advanced laboratory reagents, diagnostic tools, therapeutic agents, and research infrastructure, demonstrating deep familiarity with FDA-regulated supply chains and federal research funding frameworks.